Agreed that receipts were low last quarter showing inconsistency in revenue generation from that source.
Cash in my opinion is OK, $1.5M on hand with upcoming $1.1M rebate and additional $450k outstanding collection. Commercialization of PromarkerD continues to 'slowly' creep forward and those royalties will finally build a solid revenue base.
While experience has taught me never to take what stated in these reports as truth I do look forward to this upcoming update on Promarker D rollout.
"Currently licence partners cover Mexico, Dominican Republic and Spain, and Proteomics International looks forward to providing significant updates on the roll-out of PromarkerD in these jurisdictions in the coming weeks."
PIQ Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)